Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06311968 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor

StatusRecruiting
PhasePhase 2
SponsorJian Chen
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Start date changed from estimate of Apr 1, 2024 to May 6, 2024v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
5 trials monitored
See all monitored trials
To observe the efficacy and toxicities of post-operative (R0/R1) proton radiotherapy for locally advanced primary thymus epithelial malignancies. The primary endpoint was progression-free survival and toxicities, and the secondary endpoint was overall survival and cause-specific survival.
Trial Details
NCT Number NCT06311968
Lead Sponsor Jian Chen
Conditions
(from sponsor)
Thymus Epithelial Tumor, Proton Radiotherapy, Radiation Toxicity
Related terms Radiation Injuries, Thymic epithelial tumor
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov